SCHEMBL6009706

SCHEMBL6009706

CC1(C)CCC=C2C1CCC1C(C)(C(=O)O)CCCC21C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 1/20 0.52
PTPN1 P18031 1/20 0.52
PTGS1 P23219 3/20 0.49
POLA1 P09884 4/20 0.46
KARS1 Q15046 2/20 0.43
RXRA P19793 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
POLB P06746 1/20 0.42
APEX1 P27695 1/20 0.42
PDE4D Q08499 1/20 0.42
MMP2 P08253 1/20 0.41
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 2/20 0.40
LMNA P02545 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12704655 1.00 NR1H3 (0.52) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL14610506 0.85 NR1H3 (0.51) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL280071 0.85 NR1H3 (0.54) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL12887757 0.85 NR1H3 (0.54) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL12704708 0.84 NR1H3 (0.58) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL267305 0.84 NR1H3 (0.58) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL266932 0.84 NR1H3 (0.58) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL6008298 0.84 NR1H3 (0.58) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL12704621 0.84 NR1H3 (0.58) NR1H3PTPN1PTGS1POLA1KARS1
SCHEMBL14610508 0.84 NR1H3 (0.58) NR1H3PTPN1PTGS1POLA1KARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912932-B1 INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-A MODULATORS; SYNTHESES OF SUCH MODULATORS AND METHODS OF USING SUCH MODULATORS NEREUS PHARMACEUTICALS INC (US) 2012-05-02 EP disclosed